Literature DB >> 10654820

Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase along the nephron: new insights into renal vitamin D metabolism.

R Bland1, D Zehnder, M Hewison.   

Abstract

Renal synthesis of the active form of vitamin D, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], is a pivotal step in calcium and phosphate homeostasis. Production of 1,25(OH)2D3 is catalyzed by the mitchondrial cytochrome P450, 25-hydroxyvitamin D3-1alpha-hydroxylase (1alpha-HYD). As a consequence of the tight regulation of vitamin D metabolism during normal physiology, studies of the expression and regulation of 1alpha-HYD have proved remarkably difficult. However, the recent cloning of the gene for 1alpha-HYD has enabled a more comprehensive analysis of the tissue distribution of 1alpha-HYD, as well as the mechanisms involved in controlling 1,25(OH)2D3 production. In particular, an understanding of site-specific expression and regulation of 1alpha-HYD along the nephron might help to elucidate a more versatile role for 1,25(OH)2D3 in renal physiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10654820     DOI: 10.1097/00041552-200001000-00004

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  12 in total

1.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 2.  Disorders of calcium and magnesium balance: a physiology-based approach.

Authors:  Ewout J Hoorn; Robert Zietse
Journal:  Pediatr Nephrol       Date:  2012-11-10       Impact factor: 3.714

3.  Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency?

Authors:  Kathryn M Thrailkill; Chan-Hee Jo; Gael E Cockrell; Cynthia S Moreau; John L Fowlkes
Journal:  J Clin Endocrinol Metab       Date:  2010-10-13       Impact factor: 5.958

4.  Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy.

Authors:  Katie N Evans; Harris Taylor; Daniel Zehnder; Mark D Kilby; Judith N Bulmer; Farah Shah; John S Adams; Martin Hewison
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

5.  Ferrotoxicity and its amelioration by endogenous vitamin D in experimental acute kidney injury.

Authors:  Chandrashekar Annamalai; Rajesh N Ganesh; Pragasam Viswanathan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-02

6.  Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans.

Authors:  Anna Liza B Valiña-Tóth; Zongshan Lai; Wonsuk Yoo; Abdul Abou-Samra; Crystal A Gadegbeku; John M Flack
Journal:  Clin Endocrinol (Oxf)       Date:  2009-07-28       Impact factor: 3.478

7.  Insufficient renal 1-alpha hydroxylase and bone homeostasis in aged rats with insulin resistance or type 2 diabetes mellitus.

Authors:  Huang Chang-Quan; Dong Bi-Rong; He Ping; Lu Zhen-Chan
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

8.  Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway.

Authors:  N Liu; A T Kaplan; J Low; L Nguyen; G Y Liu; O Equils; M Hewison
Journal:  Biol Reprod       Date:  2008-11-12       Impact factor: 4.285

9.  Multifactorial hypercalcemia and literature review on primary hyperparathyroidism associated with lymphoma.

Authors:  Jelena Maletkovic; Jennifer P Isorena; Miguel Fernando Palma Diaz; Stanley G Korenman; Michael W Yeh
Journal:  Case Rep Endocrinol       Date:  2014-03-05

10.  The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua.

Authors:  Daniel Zehnder; Katie N Evans; Mark D Kilby; Judith N Bulmer; Barbara A Innes; Paul M Stewart; Martin Hewison
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.